Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Everolimus

5

VIII.a Angioedema (may cause UAO, asphyxia and death)

2
Last update : 06/07/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
MTOR inhibitors
5

Publications

Lingual angioedema associated with everolimus.
Acta oncologica (Stockholm, Sweden) 2010;49;107-9 2010
[67-year-old patient with speech disorder and dysphagia].
Deutsche medizinische Wochenschrift (1946) 2008 Nov;133;2463-4 2008 Nov
Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2007 Apr;26;305-11 2007 Apr
Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angioedema.
Transplantation 2005 Apr 27;79;981-3 2005 Apr 27

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies